Skip to player
Skip to main content
Search
Connect
Watch fullscreen
1
Share
Bookmark
More
Add to Playlist
Report
Benzinga
Follow
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
2 years ago
Eli Lilly has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’s Mounjaro lost more weight than those on Novo Nordisk’s Ozempic.
Category
🗞
News
Show less
Comments
Add your comment
Recommended
3:28
|
Up next
Stock Market Today: Dow Jones, Nasdaq Futures Slip Amid Delay In Trade Deficit Data During Shutdown—Trilogy Metals, AMD, Applovin In Focus
Benzinga
7 months ago
1:24
Nike Stock Jumps On Q1 Earnings Beat- 'We Still Have Work Ahead'
Benzinga
7 months ago
3:07
Stock Market Today: S&P 500 Futures Gain, Non Farm Payrolls Report—Broadcom, DocuSign, Lululemon In Focus
Benzinga
8 months ago
0:56
UnitedHealth Stock Falls As Department Of Justice Criminal Probe Expands To Optum Rx
Benzinga
9 months ago
0:43
Novo Tanks 25% on Surprise Demand Drop
Benzinga
10 months ago
0:37
Amazon Expands 30-Minute Delivery Push
Cheddar News
6 hours ago
0:39
GameStop’s Mega-Deal Dream Gets Shut Down
Cheddar News
8 hours ago
0:35
Musk Vs. Altman: OpenAI Court Battle Heats Up
Cheddar News
8 hours ago
24:18
haulover inlet boats
BoatSnaps
5 years ago
1:01
Execs Join China Trip
Benzinga
7 hours ago
1:10
Jobs Report Warning
Benzinga
7 hours ago
1:13
Supermicro AI Push
Benzinga
7 hours ago
0:57
OpenAI Enterprise Push
Benzinga
8 hours ago
0:56
Eisman Sides With Burry
Benzinga
8 hours ago
1:00
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Benzinga
2 years ago
1:19
Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
Benzinga
2 years ago
1:20
Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Benzinga
2 years ago
1:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
2 years ago
1:13
Why "Hims and Hers" Stock Plummeted
Benzinga
1 year ago
3:04
How End Of Month Buy And Sell Imbalances Effected Stock Movements
Benzinga
3 years ago
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
3 years ago
4:17
Apple Stock Dips After KeyBanc Cuts Rating On iPhone Sale Concerns: What Investors Need To Know
Benzinga
2 years ago
0:41
Ulta Beauty Stock Climbs On Q4 Earnings Beat: 'Fiscal 2025 Will Be A Pivotal Year'
Benzinga
1 year ago
4:15
Something Is Happening In The Utilities Sector That Investors Should Watch Out For | $XLU
Benzinga
2 years ago
1:08
As Global Markets Roil, Strategist Soothes Nerves: 'Some Normal Action Under The Surface' As 'Tech Got Way Ahead Of Itself'
Benzinga
2 years ago
Comments